β-blocker therapy for heart failure outside the clinical trial setting: Findings of a community-based registry
- 31 October 2004
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 148 (4), 718-726
- https://doi.org/10.1016/j.ahj.2004.04.006
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- 1172-71 Practical predictors of clinical outcomes in patients initiating beta-blockers for heart failure: Findings of a community-based registryJournal of the American College of Cardiology, 2004
- Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) studyJournal of the American College of Cardiology, 2001
- ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summaryJournal of the American College of Cardiology, 2001
- β-Blockers in Congestive Heart Failure: A Bayesian Meta-AnalysisAnnals of Internal Medicine, 2001
- Is the prognosis of heart failure improving?Journal of the American College of Cardiology, 2000
- Rationale, design, and methods for a Coreg (carvedilol) Heart Failure Registry (COHERE)Journal of Cardiac Failure, 2000
- Cardiology or Primary Care for Heart Failure in the Community SettingChest, 1999
- Treatment Research at the Crossroads: The Scientific Interface of Clinical Trials and Effectiveness ResearchAmerican Journal of Psychiatry, 1999
- Factors determining angiotensin‐converting enzyme inhibitor underutilization in heart failure in a community settingClinical Cardiology, 1998
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996